Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Mezzion Pharma (140410 KS)
Watchlist
21
Analysis
Health Care
•
South Korea
Mezzion Pharma Co Ltd develops pharmaceutical products and out-licenses them to foreign countries including Canada, Mexico, Russia, and the United States. The Company's main products are for benign prostatic hyperplasia and erectile dysfunction.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Mezzion Pharma
•
17 Mar 2026 15:52
KOSDAQ150 Index Adhoc Rebalance: Curiox Bio (445680 KQ) To Replace Mezzion Pharma (140410 KQ)
Mezzion Pharma has been added to the Investment Attention list and will be deleted from the KOSDAQ150 Index. Curiox Biosystems will be added to the...
Brian Freitas
Follow
552 Views
Share
bullish
•
Mezzion Pharma
•
17 Mar 2026 10:54
Primer: Mezzion Pharma (140410 KS) - Mar 2026
Mezzion Pharma is a late-stage, single-asset biopharmaceutical company whose value is almost entirely dependent on the clinical and regulatory...
αSK Primers
207 Views
Share
bullish
•
Seers
•
11 Sep 2026 20:34
An Early Look at the Potential KOSDAQ150 Rebalance Candidates in December 2026
In this insight, I provide an early look at the potential additions and deletions to KOSDAQ150 rebalance in December 2026.
Douglas Kim
Follow
115 Views
Share
bearish
•
Hong Kong Exchanges and Clearing
•
04 Nov 2019 08:45
Stock Short Ideas Within an Index Long Environment
Positioning is quickly shifting to more index net longs and we are on the hunt for stock shorts in Asia given the more bullish Q4 seasonality and...
Thomas Schroeder
548 Views
Share
bullish
•
MSCI Emerging Markets Index
•
26 Aug 2018 23:31
EM Strategy: Remain Overweight India
In this report we provide a synopsis of EM markets. We also scour the EM universe for attractive and actionable opportunities, highlighting...
Vermilion Research
Follow
613 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x